Oslo, Norway August 19th 2019. 

SoftOx Solutions (OSE: SOFTOX-ME) today announces that the company's first
clinical study on the Wound Irrigation Solution, SWIS, has now completed
inclusion of patients. The study is conducted at the Wound Center at Bispebjerg
University Hospital in Copenhagen Denmark.  
The primary aim of the study is to assess safety of SWIS together with some
efficacy indicators such as bacterial reduction and epithelialization. More
information on this study can be found at www.clinicaltrials.gov (NCT03742284). 

 “We are very pleased to have reached this important milestone for our first
medical device and look forward to receiving the results within a few months”,
says Geir Almås, Chief Executive Officer at SoftOx Solutions AS. 
 
For further information, please contact: 

Geir H. Almås, CEO 
geir.almaas@soft-ox.com 
Tel: +47 977 59 071